Celltrion
068270.KS
#709
Rank
A$45.11 B
Marketcap
$219.53
Share price
3.11%
Change (1 day)
5.94%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Cash on Hand

Cash on Hand as of June 2024 : A$1.18 Billion

According to Celltrion 's latest financial reports the company has A$1.18 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Celltrion - Cash on Hand chart (from 2007 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$0.69 B-51.01%
2021-12-31A$1.41 B69.17%
2020-12-31A$0.83 B7.8%
2019-12-31A$0.77 B14.59%
2018-12-31A$0.67 B0.95%
2017-12-31A$0.67 B112.45%
2016-12-31A$0.31 B73.28%
2015-12-31A$0.18 B37.75%
2014-12-31A$0.13 B9.89%
2013-12-31A$0.12 B25.79%
2012-12-31A$95.63 M93.88%
2011-12-31A$49.32 M-54.08%
2010-12-31A$0.10 B405.44%
2009-12-31A$21.25 M344.29%
2008-12-31A$4.78 M-8.22%
2007-12-31A$5.21 M